Evidence map›Paper›PMID 30194258›Full record

ReviewThe Journal of biological chemistry2018

Walking a fine line between β-cell secretion and proliferation.

Adrian Vella, Aleksey Matveyenko

Open access · hybridAbstract readReview
In one paragraph

Review in The Journal of biological chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Adrian VellaFrom the Division of Endocrinology and Metabolism and vella.adrian@mayo.edu.
Aleksey MatveyenkoFrom the Division of Endocrinology and Metabolism and.
Mayo Clinic · USWinnMed · US

Funding

The regulation of fasting glucose metabolism in people with and without prediabetesR01DK078646 · NIDDK · MAYO CLINIC ROCHESTER · PI Adrian Vella · 2007 to 2026
$8.7M
Role of Circadian Misalignment in Beta-cell Failure in Type 2 DiabetesR01DK098468 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ALEKSEY V MATVEYENKO · 2013 to 2026
$5.8M
Glucagon suppression and diabetes-associated variation in TCF7L2R01DK116231 · NIDDK · MAYO CLINIC ROCHESTER · PI Adrian Vella · 2017 to 2026
$5.4M
NIDDK NIH HHS R01 DK078646NIDDK NIH HHS R01 DK098468NIDDK NIH HHS R01 DK116231
6 · The paper itself

Abstract

Of the many common genetic variants associated with type 2 diabetes, that in

Indexed as

Cell ProliferationInsulin SecretionAnimalsDiabetes Mellitus, Type 2HumansInsulin-Secreting CellsTranscription Factor 7-Like 2 ProteinTCF7L2 protein, humanTranscription Factor 7-Like 2 Protein

Identifiers

PMID30194258
PMCPMC6130962
OpenAlexW2891879780

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.